COVID | Nirvana Systems Inc.

Tag Archives for " COVID "

U.S. media is far more pessimistic in covering the coronavirus pandemic than anyone else

It was sometime after the end of the first coronavirus wave that Bruce Sacerdote, a professor of economics at Dartmouth College, noticed something puzzling. “We were doing lots of staying at home and social distancing, and you could see the case numbers coming down, and I and my co-authors are watching the TV obsessively, and […]

Continue reading

From jobs to child care: How this second surge in COVID-19 can damage your finances — as well as your health

Coronavirus infection tallies are climbing relentlessly right now, but case counts aren’t the only measurement going the wrong direction. A growing number of people are finding it tough to afford enough food, pay for typical household goods and stay current on their rent and mortgage compared to five weeks prior, according to running statistics from […]

Continue reading

Home Searches in Cities Up 200% From Last Year, Reflecting Renewed Interest in Urban Areas After Pandemic-Driven Drop

SEATTLE, Nov. 24, 2020 /PRNewswire/ — (NASDAQ:RDFN) — Pageviews of homes in rural areas increased 235% year over year in October, a large increase but still a deceleration from a 273% peak in August, according to a new report from Redfin (, the technology-powered real estate brokerage. The story is similar in small towns, where pageviews rose… Read […]

Continue reading

What to expect after the Oxford-AstraZeneca COVID-19 vaccine news

U.K.-based drugmaker AstraZeneca AZN, -3.81% said on Monday that the coronavirus vaccine it is developing with the University of Oxford had shown an average efficacy of 70% in the Phase 3 trials, and that it would “immediately prepare regulatory submission” of the data for approval by regulatory authorities around the world, for conditional or early […]

Continue reading

AstraZeneca-Oxford COVID-19 vaccine can be up to 90% effective, late-stage trials show

The vaccine being developed by AstraZeneca and the University of Oxford can prevent 70.4% of people from getting COVID-19, and up to 90% if a lower dose is used. justin tallis/Agence France-Presse/Getty Images AstraZeneca and the University of Oxford said on Monday that their COVID-19 vaccine candidate was found to be as much as 90% […]

Continue reading

Decision on approving Pfizer-BioNTech vaccine to be made in ‘shortest time possible,’ U.K. regulator says

The U.K. has ordered 40 million vaccine doses from Pfizer and BioNTech – enough for up to a third of the population. justin tallis/Agence France-Presse/Getty Images The U.K.’s medicines regulator said on Monday that a decision on whether to approve the Pfizer-BioNTech coronavirus vaccine will be made in the “shortest time possible,” after receiving data […]

Continue reading